Company Filing History:
2 out of 202 
1 out of 169 
1 out of 1,309 
Years Active: 1998-2005
Title: The Innovations of Robert Warren Sullivan
Introduction
Robert Warren Sullivan is an accomplished inventor based in Oceanside, CA (US). He holds a total of 3 patents that focus on significant advancements in the treatment of inflammatory diseases. His work has contributed to the understanding and potential treatment of various health conditions.
Latest Patents
One of his latest patents involves compounds that inhibit leukocyte adhesion mediated by VLA-4. These compounds bind to VLA-4 and have shown efficacy in inhibiting leukocyte adhesion, particularly in the context of inflammatory diseases. Such compounds are beneficial for treating conditions like asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis, and myocardial ischemia. Additionally, these compounds can be utilized for treating inflammatory brain diseases, including multiple sclerosis.
Career Highlights
Throughout his career, Robert has worked with notable companies such as Elan Pharmaceuticals, Inc. and Signal Pharmaceuticals, Inc. His contributions in these organizations have been pivotal in advancing pharmaceutical research and development.
Collaborations
Robert has collaborated with esteemed colleagues, including Andrei William Konradi and Michael A Pleiss. These partnerships have fostered innovation and have been instrumental in his research endeavors.
Conclusion
Robert Warren Sullivan's work exemplifies the impact of innovative thinking in the medical field. His patents and collaborations continue to pave the way for advancements in the treatment of inflammatory diseases.